CDNA vs VCYT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

CDNA

25.1
AI Score
VS
VCYT Wins

VCYT

49.2
AI Score

Investment Advisor Scores

CDNA

25score
Recommendation
AVOID NEW MONEY

VCYT

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CDNA VCYT Winner
Forward P/E 68.9655 12.987 VCYT
PEG Ratio -0.12 0 Tie
Revenue Growth 39.3% 15.1% CDNA
Earnings Growth 1066.7% 58.3% CDNA
Tradestie Score 25.1/100 49.2/100 VCYT
Profit Margin 25.9% 21.8% CDNA
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD VCYT

Relative Price Performance (Last 90 Days)

CDNA 1M: +28.0% · 3M: +70.7% VCYT 1M: -45.3% · 3M: -46.2%

Current Technical Phase

CDNA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (20.0% over 20 days), RSI 59

RSI (14): 59.2 · Price: $80.77

VCYT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 27

RSI (14): 26.7 · Price: $24.06

Fundamentals Snapshot

Metric CDNA VCYT
Market Cap — —
Forward P/E 51.2 13.9
Trailing P/E 35.6 16.8
Revenue (TTM) — —
Revenue Growth 0.4% 0.2%
Gross Margin 0.7% 0.7%
Operating Margin 0.1% 0.1%
EPS 2.37 1.54
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, VCYT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.